The Patent Finder

Surrogate Pharmaceutical Pathways, LLC

Also on record
Records under this name other than patents Surrogate Pharmaceutical Pathways, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 9 of 9 · Back to Surrogate Pharmaceutical Pathways, LLC

PatentTitleStatus Expires Confidence
US 7,157,083Compositions and methods for treating retroviral infections
Lapsed on the fee record
Ended Jan 2, 2011 · From the USPTO record
Lapsed on the fee recordEnded Jan 2, 2011From the USPTO record
US 5,529,987Hyaluronic acid-urea pharmaceutical compositions and uses
Term ended
Term ended no later than Jun 25, 2016 · Low confidence
Term endedTerm ended no later than Jun 25, 2016Low confidence
US 5,550,112Hyaluronic acid-urea pharmaceutical compositions and uses
Term ended
Term ended no later than Aug 27, 2016 · Low confidence
Term endedTerm ended no later than Aug 27, 2016Low confidence
US 5,583,118Method of treating an anorectal disease using hyaluronic acid-urea pharmaceutical compositions
Term ended
Term ended no later than Dec 10, 2016 · Low confidence
Term endedTerm ended no later than Dec 10, 2016Low confidence
US 5,583,119Hyaluronic acid-urea pharmaceutical compositions and uses
Term ended
Term ended no later than Dec 10, 2016 · Low confidence
Term endedTerm ended no later than Dec 10, 2016Low confidence
US 5,583,120Hyaluronic acid-urea pharmaceutical compositions and uses
Term ended
Term ended no later than Dec 10, 2016 · Low confidence
Term endedTerm ended no later than Dec 10, 2016Low confidence
US 5,624,915Hyaluronic acid-urea pharmaceutical compositions and uses
Term ended
Term ended no later than Apr 29, 2017 · Low confidence
Term endedTerm ended no later than Apr 29, 2017Low confidence
US 5,631,242Hyaluronic acid-urea pharmaceutical compositions utilized for treatment of diseases of cutis
Term ended
Term ended no later than May 20, 2017 · Low confidence
Term endedTerm ended no later than May 20, 2017Low confidence
US 5,679,655Method of treating lesions resulting from genital herpes with hyaluronic acid-urea pharmaceutical compositions
Term ended
Term ended no later than Oct 21, 2017 · Low confidence
Term endedTerm ended no later than Oct 21, 2017Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited